TRANEXAMIC ACID TAB
Clinical Criteria Summary
Exclusion Criteria
- Hypersensitivity
- Concomitant use of combined hormonal contraceptives (contraindicated per U.S. product label due to increased risk of venous or arterial thromboembolism based on pharmacodynamics and postmarketing events, particularly in patients who are obese or cigarette smokers)
- History of or active thromboembolic disease or intrinsic risk of thrombosis or thromboembolism, including retinal vein or artery occlusion